KRYS

Krystal Biotech (KRYS)

Krystal Biotech Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:KRYS

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/08	07:09	PR Newswire (US)	KKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600	NASDAQ:KRYS	Krystal Biotech Inc
2024/06/05	20:00	GlobeNewswire Inc.	Krystal Biotech to Present at Goldman Sachs 45th Annual Global Healthcare Conference	NASDAQ:KRYS	Krystal Biotech Inc
2024/05/22	05:38	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KRYS	Krystal Biotech Inc
2024/05/15	20:00	GlobeNewswire Inc.	Krystal Biotech to Present at the American Thoracic Society 2024 International Conference	NASDAQ:KRYS	Krystal Biotech Inc
2024/05/08	20:00	GlobeNewswire Inc.	Krystal Biotech to Present at BofA Securities 2024 Health Care Conference	NASDAQ:KRYS	Krystal Biotech Inc
2024/05/06	21:17	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:KRYS	Krystal Biotech Inc
2024/05/06	21:09	IH Market News	Index Futures Point to Strong Monday Opening, Building on Last Week’s Gains; Oil Prices Rise	NASDAQ:KRYS	Krystal Biotech Inc
2024/05/06	21:04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KRYS	Krystal Biotech Inc
2024/05/06	21:00	GlobeNewswire Inc.	Krystal Biotech Announces First Quarter 2024 Financial Results and Provides Business Updates	NASDAQ:KRYS	Krystal Biotech Inc
2024/05/02	20:00	GlobeNewswire Inc.	Krystal Biotech to Present at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting	NASDAQ:KRYS	Krystal Biotech Inc
2024/04/26	20:00	GlobeNewswire Inc.	Krystal Biotech to Report First Quarter 2024 Financial Results on May 6, 2024	NASDAQ:KRYS	Krystal Biotech Inc
2024/04/22	20:00	GlobeNewswire Inc.	Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the Lung	NASDAQ:KRYS	Krystal Biotech Inc
2024/04/04	20:00	GlobeNewswire Inc.	Krystal Biotech to Present at the American Association for Cancer Research 2024 Annual Meeting	NASDAQ:KRYS	Krystal Biotech Inc
2024/03/02	10:20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KRYS	Krystal Biotech Inc
2024/03/02	10:16	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KRYS	Krystal Biotech Inc
2024/02/29	11:33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KRYS	Krystal Biotech Inc
2024/02/28	21:00	GlobeNewswire Inc.	Krystal Biotech to Present at TD Cowen 44th Annual Health Care Conference	NASDAQ:KRYS	Krystal Biotech Inc
2024/02/27	03:35	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:KRYS	Krystal Biotech Inc
2024/02/26	22:04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:KRYS	Krystal Biotech Inc
2024/02/26	22:00	GlobeNewswire Inc.	Krystal Biotech Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates	NASDAQ:KRYS	Krystal Biotech Inc
2024/02/26	21:59	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:KRYS	Krystal Biotech Inc
2024/02/26	21:49	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:KRYS	Krystal Biotech Inc
2024/02/26	19:57	IH Market News	U.S. Index Futures Dip Amid Inflation Data Anticipation, Oil and Iron Ore Prices Retreat	NASDAQ:KRYS	Krystal Biotech Inc
2024/02/20	21:00	GlobeNewswire Inc.	Krystal Biotech to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024	NASDAQ:KRYS	Krystal Biotech Inc
2024/02/13	21:00	GlobeNewswire Inc.	Krystal Biotech Receives FDA Fast Track Designation for Inhaled Oncology Candidate KB707 to Treat Solid Tumors of the Lung	NASDAQ:KRYS	Krystal Biotech Inc
2024/02/08	21:00	GlobeNewswire Inc.	Krystal Biotech Announces Publication in the New England Journal of Medicine on the Application of B-VEC to Treat Ocular Complications in Patient with Dystrophic Epidermolysis Bullosa	NASDAQ:KRYS	Krystal Biotech Inc
2024/02/01	21:00	GlobeNewswire Inc.	Krystal Biotech to Present at Guggenheim 6th Annual Biotechnology Conference	NASDAQ:KRYS	Krystal Biotech Inc
2024/01/25	07:44	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:KRYS	Krystal Biotech Inc
2024/01/23	01:43	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:KRYS	Krystal Biotech Inc
2024/01/04	21:00	GlobeNewswire Inc.	Krystal Biotech Receives Permanent J-code (J3401) for VYJUVEK®	NASDAQ:KRYS	Krystal Biotech Inc